Programska knjižnica 9. Lošinjskih dana bioetike - Hrvatsko ...

MEDICINE IN SERVICE OF CORPORATE INTERESTS
In the last few decades the private sector, i.e. private enterprise has
entered the medicine and health systems. In this rewarding area, in which
no boundaries were set for them, manufacturers of various medical products
have taken over a considerable part of the medical science, education,
clinical practice and politics. The most powerful among them, the
pharmaceutical industry, already clearly misuses the system, hence profit,
not curing and preventing disease becomes its main aim and motive.
Health systems spend more and more money on drugs, a lot of medicines
in use lack evidence of effectiveness, while harm caused by medication is
increasing. There is no progress in treating and eradicating diseases; they
are kept chronic and the new ones are being artificially created, making
large populations of people without health difficulties eligible for pharmacotherapy.
Under the influence of industry, the complex concept of curing
and preventing disease becomes reduced to taking pills, physician-patient
relationship gets dehumanized and medicine itself changes its paradigm
from traditionally curative to preventive.
ŽIVKA STANIČIĆ
Farmaceutsko-biokemijski fakultet, Sveučilište u Zagrebu, Hrvatska /
Faculty of Pharmacy and Biochemistry, University of Zagreb, Croatia
MOGU LI LJEKARNICI U DRUŠTVU
DEREGULIRANOG KAPITALIZMA POMIRITI SVOJ
KOMERCIJALNI INTERES I PROFESIONALNU ETIKU?
Ili: Kako ljekarnik kotira
u predodžbenom svijetu suvremenog čovjeka?
Hoće li izostanak farmaceutske profesionalne etike biti tek primjer pojedinačne
i iznimne, iako nimalo naivne pokvarenosti ili će, pak, postati
stanje pokvarenosti koje se nezadrživo i kapilarno širi u društvu, u krajnjoj
konzekvenciji ovisi o tome da li postoji optimum regulacije.
Zakon o deregulaciji lijekova to, zacijelo, nije; on, naime, omogućava
farmaceutskoj industriji i ljekarnicima da se »odmetnu« od svog primar-
166